Healthcare Fraud Detection Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Healthcare Fraud Detection Market Report is Segmented by Analytics Type (Descriptive Analytics, Predictive Analytics, and More), Component (Software and Services), Deployment Mode (On-Premise, Cloud and More), Application (Review of Insurance Claims, Payment Integrity and More), End User (Private Insurance Payers, Government Agencies, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Healthcare Fraud Detection Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Healthcare Fraud Detection Market with other markets in Healthcare Industry

Healthcare Fraud Detection Market Analysis by Mordor Intelligence

The healthcare fraud detection market reached a value of USD 2.69 billion in 2025 and is forecast to climb to USD 6.74 billion by 2030, implying a sturdy 20.11% CAGR. Across the forecast window, payers and providers are expanding data-driven fraud and payment-integrity programs in response to an estimated USD 100 billion in annual fraud losses.[1]Centers for Medicare & Medicaid Services, “Crushing Fraud, Waste, & Abuse,” cms.gov Wider adoption of real-time analytics, cloud infrastructure, and FHIR-based interoperability is turning fraud-detection from an after-the-fact review into a proactive risk-control discipline. Government audits are intensifying—CMS alone will raise its medical-record review workforce from 40 to 2,000 coders—which, in turn, is spurring technology vendors to embed machine learning and generative AI into core claims workflows. Competitive differentiation now hinges on rapid model deployment, partner ecosystems, and the ability to process unstructured clinical data at scale. Implementation challenges remain—especially around data integration, transparency mandates, and staff change-management—yet the cost-benefit equation increasingly favors automated fraud detection as a must-have, not a “nice-to-have,” capability.

Key Report Takeaways

  • By analytics type, predictive analytics led with 44.37% revenue share in 2024, while real-time streaming analytics is poised for a 24.56% CAGR through 2030. 
  • By component, software platforms held 59.86% of the healthcare fraud detection market share in 2024 and cloud services are expanding at 23.73% CAGR to 2030. 
  • By deployment mode, cloud deployments commanded 57.85% of the healthcare fraud detection market size in 2024 and will advance at 23.05% CAGR through 2030. 
  • By application, review of insurance claims captured 50.53% share of the healthcare fraud detection market size in 2024, whereas pharmacy benefit management is accelerating at a 22.14% CAGR. 
  • By end user, private insurance payers accounted for 47.69% revenue share in 2024, with government agencies registering the fastest 22.89% CAGR. 
  • By geography, North America led with 41.78% 2024 share, while Asia-Pacific is forecast to post a 21.34% CAGR through 2030.

Segment Analysis

By Analytics Type: Real-Time Processing Drives Innovation

The healthcare fraud detection market size for analytics platforms was led by predictive tools, which captured 44.37% share in 2024. These models profile historical claims to forecast risk before payment. Nonetheless, demand is shifting toward real-time streaming analytics, forecast to climb at 24.56% CAGR through 2030. Organizations increasingly view millisecond-level scoring as essential for intercepting evolving schemes.

Stream-processing stacks such as Kafka and Flink underpin this pivot, enabling dynamic ingestion of unstructured notes, device data, and FHIR messages. Early adopters report materially lower overpayment rates once detections occur pre-payment rather than in retrospective audits. Descriptive analytics remains relevant for compliance reporting, while prescriptive models are emerging among mature payers seeking automated adjudication recommendations. Vendors that knit predictive, prescriptive, and real-time workflows into a single fabric are shaping the next wave of differentiation in the healthcare fraud detection market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Component: Cloud Services Accelerate Deployment

Software suites dominated the component landscape with 59.86% 2024 share, reflecting entrenched demand for end-to-end investigation platforms. Yet cloud services are the fastest-growing slice at 23.73% CAGR, propelled by migration away from rigid on-premise stacks. Payers cite elastic scaling, lower upfront cost, and faster update cycles as prime incentives.

Major alliances—Humana and Google Cloud, Oracle Health and G42—aim to marry deep health data with hyperscale infrastructure. This ecosystem approach lowers barriers for mid-market insurers that lack vast internal IT. In parallel, managed-service providers bundle model governance, system tuning, and regulatory reporting, thereby reshaping total-cost calculations. As health plans consolidate point solutions into unified SaaS platforms, cloud services are likely to become the de-facto delivery model for the healthcare fraud detection market.

By Deployment Mode: Hybrid Models Enable Flexibility

Cloud deployments already account for 57.85% of the healthcare fraud detection market size and are projected to keep expanding at 23.05% CAGR. Even so, on-premise installations persist inside organizations with stringent data-sovereignty mandates. Hybrid architectures reconcile these needs, allowing sensitive identifiers to stay in local vaults while compute-heavy analytics runs in the cloud.

The rise of FHIR-native APIs from vendors such as Health Samurai simplifies secure data exchange between environments. Hybrid designs also help firms throttle cloud spending by off-loading only peak-time workloads. Over the forecast horizon, regulators’ evolving stance on cross-border data transfer will likely determine how fast pure cloud deployments outpace hybrid models, but flexibility will remain an essential buying criterion.

By Application: Pharmacy Benefits Drive Growth

Claims review retained 50.53% share in 2024, anchoring the healthcare fraud detection market. Yet pharmacy benefit management (PBM) solutions will expand at 22.14% CAGR, mirroring the surge in prescription-drug spend and scrutiny of high-cost therapies. Fraud models tuned to formulary management detect doctor-shopping, refill abuse, and coupon gaming that ordinary claims edits overlook.

CMS investigations into anomalous catheter billing underscore how device-specific schemes can slip through generic rule sets. With real-time PBM analytics, payers flag suspect prescriptions at the pharmacy counter, averting waste before dispensing. Adjacent use cases—payment integrity, provider audit, and revenue recovery—continue to mature, creating a continuum of prevention, detection, and recoupment applications inside the broader healthcare fraud detection market.

Healthcare Fraud Detection Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Government Agencies Accelerate Adoption

Private insurance payers dominated demand with 47.69% revenue share in 2024 because commercial plans historically invested earliest in analytics. However, government agencies will log the fastest 22.89% CAGR as Medicare and Medicaid scale machine-learning audits. CMS’s Data Analytics and Systems Group exemplifies this shift, coordinating cross-program integrity efforts with advanced modeling.

Providers are also stepping up investment to tighten revenue-cycle management under value-based contracts. Meanwhile, employers and unions deploy member-centric fraud tools to curb premium growth. This widening stakeholder roster broadens addressable demand and diversifies solution requirements, reinforcing the need for configurable platforms within the healthcare fraud detection market.

Geography Analysis

North America held 41.78% share of the healthcare fraud detection market in 2024, anchored by robust enforcement frameworks and funding. CMS is channeling USD 941 million into fraud-control activities for fiscal 2025, and regulations such as the 21st Century Cures Act mandate interoperability and algorithm transparency. High EHR penetration and a dense vendor ecosystem speed adoption cycles. Canada and Mexico follow the U.S. trajectory as cross-border claims rise and shared data lakes emerge.

Asia-Pacific is the fastest-growing region with a 21.34% CAGR, fueled by nationwide digital-health missions, expanding insurance pools, and cloud-first IT strategies. India’s 500-million-plus health IDs, China’s AI productivity gains among clinicians, and Japan’s insurer-led generative-AI pilots exemplify momentum. Australia and South Korea add regulatory clarity and public grants that accelerate vendor uptake.

Europe maintains solid growth underpinned by GDPR-aligned privacy safeguards. Member states adopt privacy-preserving analytics and synthetic data to reconcile fraud prevention with stringent data-protection norms. Germany, United Kingdom, and France lead deployments through national digitization roadmaps, while Southern and Eastern European markets show steady demand as health-insurance coverage broadens. South America and the Middle East & Africa remain nascent but attractive, given rising private insurance penetration and government e-health agendas that will require fraud controls.

Healthcare Fraud Detection Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Competition clusters around integrated, AI-driven platforms supplied by global technology houses, legacy healthcare-IT vendors, and nimble startups. Market leaders pursue acquisitions and alliances to fill capability gaps and strengthen cloud and analytics depth. HEALWELL AI’s USD 165 million takeover of Orion Health underscores a consolidation trend toward data-interoperability plus AI bundles.

Oracle Health’s partnership with Cleveland Clinic and G42 signals a push to co-develop nation-scale AI applications that incorporate fraud-scoring at their core. UnitedHealth Group, with more than 1,000 AI use cases live, illustrates the capital intensity required to sustain leadership. 

Emerging disruptors differentiate via cloud-native, microservice architectures that slash deployment time and enable rapid algorithm iteration. White-space opportunities include synthetic-data generators, bias-auditing toolkits, and pre-payment “Point-Zero” integrity models like Codoxo’s newly launched service. Overall, buyers weigh vendor roadmaps, explainability features, and multi-channel data ingestion more heavily than initial software cost when selecting platforms in the healthcare fraud detection market.

Healthcare Fraud Detection Industry Leaders

  1. CGI Inc.

  2. DXC Technology Company

  3. Mckesson

  4. IBM

  5. Exl Service

  6. *Disclaimer: Major Players sorted in no particular order
CL-HFDM.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • May 2025: Codoxo launched Point Zero Payment Integrity, a pre-claim intervention model aimed at preventing improper payments.
  • April 2025: Perfios acquired IHX to merge health-data insights with a large claims-exchange network.
  • April 2025: CGI Federal released a federal Fraud, Waste and Abuse Prevention Platform to stop improper payments pre-disbursement.
  • February 2025: Commure and Athelas agreed to acquire Augmedix, forming the largest AI software provider in healthcare with extensive denied-claim automation.

Table of Contents for Healthcare Fraud Detection Industry Report

1. Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Healthcare Expenditure
    • 4.2.2 Increasing Fraudulent Activities In Healthcare
    • 4.2.3 Growing Pressure To Reduce Healthcare Spending
    • 4.2.4 Surge In Health-Insurance Enrolment & Claims Volumes
    • 4.2.5 Real-Time Claims Adjudication Via FHIR APIs
    • 4.2.6 Synthetic Data Generation For Cross-Institution Pattern Detection
  • 4.3 Market Restraints
    • 4.3.1 Unwillingness To Adopt Analytics Solutions
    • 4.3.2 High Implementation & Integration Costs
    • 4.3.3 Data-Privacy & Compliance Concerns (HIPAA / GDPR)
    • 4.3.4 AI-Model Bias & False Positives Triggering Scrutiny
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technology Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Bargaining Power of Suppliers
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size and Growth Forecasts (Value-USD)

  • 5.1 By Analytics Type
    • 5.1.1 Descriptive Analytics
    • 5.1.2 Predictive Analytics
    • 5.1.3 Prescriptive Analytics
    • 5.1.4 Real-time / Streaming Analytics
  • 5.2 By Component
    • 5.2.1 Software
    • 5.2.2 Services
  • 5.3 By Deployment Mode
    • 5.3.1 On-premise
    • 5.3.2 Cloud
    • 5.3.3 Hybrid
  • 5.4 By Application
    • 5.4.1 Review of Insurance Claims
    • 5.4.2 Payment Integrity
    • 5.4.3 Provider Audit & Revenue Recovery
    • 5.4.4 Fraud, Waste & Abuse Management
    • 5.4.5 Pharmacy Benefit Management
  • 5.5 By End User
    • 5.5.1 Private Insurance Payers
    • 5.5.2 Government Agencies
    • 5.5.3 Healthcare Providers
    • 5.5.4 Employers & Unions
  • 5.6 By Geography
    • 5.6.1 North America
    • 5.6.1.1 United States
    • 5.6.1.2 Canada
    • 5.6.1.3 Mexico
    • 5.6.2 Europe
    • 5.6.2.1 Germany
    • 5.6.2.2 United Kingdom
    • 5.6.2.3 France
    • 5.6.2.4 Italy
    • 5.6.2.5 Spain
    • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
    • 5.6.3.1 China
    • 5.6.3.2 Japan
    • 5.6.3.3 India
    • 5.6.3.4 Australia
    • 5.6.3.5 South Korea
    • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
    • 5.6.4.1 GCC
    • 5.6.4.2 South Africa
    • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
    • 5.6.5.1 Brazil
    • 5.6.5.2 Argentina
    • 5.6.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.3.1 UnitedHealth Group
    • 6.3.2 SAS Institute Inc.
    • 6.3.3 IBM Corporation
    • 6.3.4 Cotiviti, Inc.
    • 6.3.5 Fair Isaac Corporation (FICO)
    • 6.3.6 LexisNexis Risk Solutions
    • 6.3.7 BAE Systems plc
    • 6.3.8 DXC Technology
    • 6.3.9 CGI Inc.
    • 6.3.10 EXL Service Holdings
    • 6.3.11 McKesson Corporation
    • 6.3.12 Northrop Grumman
    • 6.3.13 Oracle Corporation
    • 6.3.14 ClarisHealth
    • 6.3.15 Change Healthcare
    • 6.3.16 Pegasystems Inc.
    • 6.3.17 Codoxo
    • 6.3.18 C3.ai
    • 6.3.19 OSP Labs
    • 6.3.20 SCIO Health Analytics

7. Market Opportunities and Future Outlook

  • 7.1 White-Space and Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Healthcare Fraud Detection Market Report Scope

As per the scope of the report, the term 'healthcare fraud detection' refers to solutions that are helpful in the early detection of errors in claim submissions, duplication of claims, etc., to minimize healthcare spending and improve efficiency. The healthcare fraud detection market is segmented by Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics), Application (Review of Insurance Claims and Payment Integrity), End User (Private Insurance Payers, Government Agencies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Analytics Type Descriptive Analytics
Predictive Analytics
Prescriptive Analytics
Real-time / Streaming Analytics
By Component Software
Services
By Deployment Mode On-premise
Cloud
Hybrid
By Application Review of Insurance Claims
Payment Integrity
Provider Audit & Revenue Recovery
Fraud, Waste & Abuse Management
Pharmacy Benefit Management
By End User Private Insurance Payers
Government Agencies
Healthcare Providers
Employers & Unions
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Analytics Type
Descriptive Analytics
Predictive Analytics
Prescriptive Analytics
Real-time / Streaming Analytics
By Component
Software
Services
By Deployment Mode
On-premise
Cloud
Hybrid
By Application
Review of Insurance Claims
Payment Integrity
Provider Audit & Revenue Recovery
Fraud, Waste & Abuse Management
Pharmacy Benefit Management
By End User
Private Insurance Payers
Government Agencies
Healthcare Providers
Employers & Unions
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

1. What is the current value of the healthcare fraud detection market?

The market stands at USD 2.69 billion in 2025 and is projected to reach USD 6.74 billion by 2030, reflecting a 20.11% CAGR.

2. Which analytics approach is growing fastest?

Real-time streaming analytics is the fastest-growing segment, expected to post a 24.56% CAGR through 2030.

3. Why are cloud services gaining traction in fraud detection?

Cloud platforms offer elastic scaling, lower upfront costs, and rapid deployment, supporting a 23.73% CAGR for cloud services within the market.

4. Which region will expand most quickly?

Asia-Pacific is forecast to grow at a 21.34% CAGR, propelled by large-scale digital-health programs and rising insurance coverage.

5. How are government agencies influencing market growth?

Agencies such as CMS are ramping up audits and funding; government end users are anticipated to witness a 22.89% CAGR in solution adoption.

6. What is the biggest barrier to adopting fraud-detection analytics?

High implementation and integration costs remain the primary restraint, particularly for smaller healthcare organizations.

Page last updated on: June 27, 2025

Healthcare Fraud Detection Market Report Snapshots